Myeloma Minute: IMF at #ASH17

Tune Into the IMF Pre-ASH Satellite Symposium Livestream

Watch the IMF’s Satellite Symposium live online at 9:30 a.m. PT / 12:30 p.m. ET on Friday, December 8, 2017, preceding the 59th American Society of Hematology (ASH) Annual Meeting. Listen to a lively discussion with international myeloma experts who will share their perspectives on new data, guideline changes, and recommendations for management of patients with multiple myeloma.​


Watch the IMF's IMWG Conference Series Debate Live from ASH

The ASH 2017 meeting caps off with an International Myeloma Working Group (IMWG) Conference Series livestream. Watch this broadcast online at 4 p.m. PT / 7 p.m. ET on Monday, December 11, 2017. IMF Chairman Dr. Brian Durie will moderate and be joined by IMWG members Dr. Joseph Mikhael (Mayo Clinic Scottsdale, AZ) and Dr. Paul G. Richardson (Dana-Farber Cancer Institute Boston, MA) to discuss questions facing myeloma doctors and patients in light of the latest research presented at ASH.


New Late-Stage Trials Launched to Study Combination Treatments for Multiple Myeloma

Phase 3 clinical trials have been launched to study isatuximab in combination with other agents to treat patients either in the frontline setting or with relapsed myeloma. Isatuximab is an investigational anti-CD38 monoclonal antibody and was granted orphan designation in the U.S. and the European Union in December 2016.

2018 Open Enrollment for the Affordable Care Act Ends Soon

You can enroll in or change 2018 marketplace health insurance right now. The 2018 Open Enrollment Period runs from now to December 15, 2017.

Myeloma Support Group Leaders Travel to Atlanta for ASH 2017

Yelak Biru, 22-year multiple myeloma survivor and patient advocate, writes in his blog about myeloma treatments that were available when he was first diagnosed to the many options available now. Follow Yelak and 11 other IMF myeloma Support Group Leaders as they report live from ASH from December 8, 2017, to December 12, 2017. Of note, Yelak’s long-term survivor perspective is also highlighted in this Cure Today article, “What Comes Next for Cancer Survivors?”

Kind and Compassionate Assistance at Your Fingertips

We'd like to remind you that the IMF InfoLine is available to take your calls at 1-800-452-CURE (2873)* from 9 a.m. to 4 p.m. PT Monday to Friday, or by email at [email protected]. Our team of trained Information Specialists consistently provides callers with the best information about myeloma in a caring and compassionate manner. *Outside the U.S. and Canada, the InfoLine may be reached at 1-818-487-7455. Please note that the InfoLine will be closed from December 20, 2017 until January 2, 2018.

What are the most important abstracts at the 2017 ASH annual meeting?

In this week’s video, Dr. Brian G.M. Durie highlights his choice of the top 5 most exciting myeloma-related abstracts at ASH 2017.

This weekly newsletter is supported from funds by donors like you. Donate to continue to make publications like this one possible.

We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology




Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.